Literature DB >> 2907547

Increased vasodilator response to acetylcholine of renal blood vessels from diabetic rats.

R Bhardwaj1, P K Moore.   

Abstract

The vasodilator effect of acetylcholine (ACh) and nitroprusside and the vasoconstrictor effect of noradrenaline was assessed in the perfused kidney of streptozocin diabetic rats. Compared with control animals injected with acidified saline, the renal vasoconstrictor effect of noradrenaline was increased in diabetic rats both in terms of the dose required to produce 50% of the maximal effect (EC50) and in the maximal response achieved. The renal vasodilator effect of ACh (but not nitroprusside) was similarly enhanced in diabetic animals. The effect of ACh (but not nitroprusside) in the perfused kidney of both control and diabetic rats was reduced or abolished by mepacrine (10 microM), metyrapone (10 microM) or methylene blue (100 microM) suggesting that ACh exhibits vasodilator activity in the rat kidney by virtue of releasing endothelium derived relaxing factor (EDRF). These results are in contrast to previous published reports demonstrating reduced biosynthesis of EDRF in the aorta of diabetic rats. The mechanism which underlies the increased renal vascular response to ACh is not known. However, increased endothelial cell turnover or cholinoceptor number, elevated activity of enzyme(s) which synthesis EDRF or hyperresponsiveness of vascular smooth muscle to released EDRF should all be considered.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2907547     DOI: 10.1111/j.2042-7158.1988.tb07009.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  7 in total

1.  The effect of insulin treatment and of islet transplantation on the resistance artery function in the STZ-induced diabetic rat.

Authors:  K M Heygate; J Davies; M Holmes; R F James; H Thurston
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

Review 2.  Endothelial dysfunction in diabetes.

Authors:  A S De Vriese; T J Verbeuren; J Van de Voorde; N H Lameire; P M Vanhoutte
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

3.  Epidermal growth factor receptor tyrosine kinase-mediated signalling contributes to diabetes-induced vascular dysfunction in the mesenteric bed.

Authors:  Ibrahim F Benter; Mariam H M Yousif; Sioned M Griffiths; Mustapha Benboubetra; Saghir Akhtar
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

4.  The effects of endothelin-1 and NG-nitro-L-arginine methyl ester on regional haemodynamics in conscious rats with streptozotocin-induced diabetes mellitus.

Authors:  R J Kiff; S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

5.  Sex differences in mesenteric endothelial function of streptozotocin-induced diabetic rats: a shift in the relative importance of EDRFs.

Authors:  Rui Zhang; Der Thor; Xiaoyuan Han; Leigh Anderson; Roshanak Rahimian
Journal:  Am J Physiol Heart Circ Physiol       Date:  2012-09-14       Impact factor: 4.733

6.  Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus.

Authors:  R J Kiff; S M Gardiner; A M Compton; T Bennett
Journal:  Br J Pharmacol       Date:  1991-06       Impact factor: 8.739

7.  Effects of streptozotocin-induced diabetes on the pharmacology of rat conduit and resistance intrapulmonary arteries.

Authors:  Alison M Gurney; Frank C Howarth
Journal:  Cardiovasc Diabetol       Date:  2009-01-21       Impact factor: 9.951

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.